Rechallenge and Retreatment with Topical Imiquimod 5% in Transplant Recipients: A Multicenter Experience on Actinic Keratoses and Basal Cell Carcinomas
JEADV CLINICAL PRACTICE（2024）
Key words
imiquimod,immunomodulation,nonmelanoma skin cancer,transplant recipients
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined